|
Market Cap (6-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 6 November 2020, 10:58. The announcement is not marked as price sensitive, and is 13 page(s) in length and 610.16kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.000% short sold according to ASIC data. It was ranked the 585th most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| AGM Chairman's Address and CEO Presentation | 6 November 2020, 10:58 |
| Grants Awarded to Support Clinical Progression of Lead Drug | 29 October 2020, 8:04 |
| Notice under Section 708(A) | 28 October 2020, 17:42 |
| Change of Director's Interest Notice x 2 | 28 October 2020, 16:37 |
You must be logged in to post a reply.
